======= PRKG2 =======
== Gene Information ==
* **Official Symbol**: PRKG2
* **Official Name**: protein kinase cGMP-dependent 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5593|5593]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q13237|Q13237]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PRKG2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRKG2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601591|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Crucial regulator of intestinal secretion and bone growth (By similarity). Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (By similarity). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595}.
|Pkinase|
|cNMP binding|
|Pkinase Tyr|
|cGMP-dependent protein kinase activity|
|negative regulation of chloride transport|
|peptidyl-serine autophosphorylation|
|regulation of chloride transport|
|cAMP-dependent protein kinase activity|
|cAMP-dependent protein kinase complex|
|cGMP binding|
|negative regulation of anion transport|
|regulation of anion transport|
|negative regulation of ion transport|
|peptidyl-serine phosphorylation|
|protein localization to plasma membrane|
|protein autophosphorylation|
|peptidyl-serine modification|
|protein localization to cell periphery|
|protein kinase activity|
|nuclear membrane|
|apical plasma membrane|
|cofactor metabolic process|
|protein localization to membrane|
|negative regulation of transport|
|regulation of ion transport|
|protein homodimerization activity|
|peptidyl-amino acid modification|
|protein phosphorylation|
|phosphorylation|
|ATP binding|
|cellular protein localization|
|cellular macromolecule localization|
|regulation of transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp112|S-DABN 8μM R03 exp112]]|-1.81|
|[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|1.7|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.71|
|[[:results:exp148|SB202190 10μM R03 exp148]]|1.72|
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.75|
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.76|
|[[:results:exp372|Ibrutinib 1μM R07 exp372]]|1.86|
|[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|2|
|[[:results:exp382|Palbociclib 1μM R07 exp382]]|2.06|
|[[:results:exp122|Golgicide-A 4μM R03 exp122]]|2.12|
|[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|2.24|
|[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|2.29|
|[[:results:exp392|PT-1 25μM R07 exp392]]|2.76|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11557
* **Expression level (log2 read counts)**: -2.51
{{:chemogenomics:nalm6 dist.png?nolink |}}